The Global Hepatitis Vaccine Market Size accounted for USD 6.87 Billion in 2024 and is estimated to achieve a market size of USD 11.03 Billion by 2032 growing at a CAGR of 5.5% from 2025 to 2033.
The global hepatitis vaccine market is a rapidly growing sector driven by the increasing global burden of hepatitis infections, rising awareness of the importance of vaccination, and advancements in vaccine development. Hepatitis is a major public health issue worldwide, with viral hepatitis being responsible for millions of deaths annually due to liver disease, cirrhosis, and liver cancer. The World Health Organization (WHO) estimates that approximately 325 million people worldwide are living with chronic hepatitis B or C, and these infections remain a leading cause of morbidity and mortality. Hepatitis vaccines play a crucial role in preventing these infections, and their widespread use has been a cornerstone of global efforts to reduce the prevalence of viral hepatitis. The hepatitis vaccine market is expected to experience significant growth due to the increasing demand for vaccination programs, growing government and healthcare sector initiatives, and innovations in vaccine development aimed at expanding coverage and improving efficacy.
Hepatitis Vaccine Market Segmentation
The worldwide market for hepatitis vaccine is split based on indication, vaccine type, distribution channel, and geography.
Hepatitis Vaccine Indication
Hepatitis A
Hepatitis B
Hepatitis Vaccine Type
Recombinant Vaccine
Inactivated Vaccine
Hepatitis Vaccine Distribution Channel
Hospitals
Retail Pharmacy
Online Pharmacy
Hepatitis Vaccine Market Regional Outlook
North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Rest of Europe
Asia-Pacific
India
Japan
China
Australia
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Rest of LATAM
The Middle East & Africa
South Africa
GCC Countries
Rest of the Middle East & Africa (ME&A)
Hepatitis Vaccine Market Players
Some of the top hepatitis vaccine companies offered in our report include GSK plc, DYNAVAX TECHNOLOGIES, VBI Vaccines Inc., Sanofi, Merck & Co., Inc., Takeda Pharmaceutical Company Limited, Sinovac Biotech Ltd., Biokangtai, Pfizer Inc., and Gilead Sciences, Inc.
How Acumen Research and Consulting Reserch Study of helps clients in their decision making:
Creating strategies for new product development
Supporting & Adjust Investment/business decisions
Benchmark and judge own competitiveness
Aiding in the business planning process
Serving as a credible, independent check on company internal forecasts
Supporting acquisition strategies
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook